Soorena Fatehchehr, MD
Urogynecology and Reconstructive Pelvic Surgery · Long Beach, CANPI 1891081253
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (37.4%), food and beverage and other — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Intuitive Surgical at 52.0% of the total.
Across 48 payments — averaging $181.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Integra Lifesciences Corporation$2K
- Coloplast$378
- AbbVie$281
- Biotissue Holdings Inc.$280
- Caldera Medical, Inc$229
- plus $650 from 12 others
What the payments were for
- Travel & lodging$5506%
- Food & beverage$2,53329%
- Education$3,24737%
- Gifts$441%
- Other$2,31627%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $4,516 |
| Integra Lifesciences Corporation | 4 | $2,357 |
| Coloplast | 10 | $378 |
| AbbVie(2 entities) | 5 | $281 |
| Biotissue Holdings Inc. | 4 | $280 |
| Caldera Medical, Inc | 3 | $229 |
| Axonics, Inc. | 1 | $159 |
| Acell, Inc. | 1 | $107 |
| Conmed Corporation | 1 | $107 |
| Boston Scientific | 1 | $48 |
| Applied Medical Resources Corporation | 1 | $44 |
| Lilly USA, LLC | 2 | $34 |
| Mimedx Group, Inc. | 1 | $30 |
| Organon | 1 | $26 |
| AMAG Pharmaceuticals, Inc. | 1 | $25 |
| Chiesi USA, Inc. | 1 | $25 |
| Solventum Corporation | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,322
- AMNIOEXCEL PLUS$2,316
- Bulkamid$159
- ALTIS$107
- AIRSEAL$107
- Desara$103
- RESTORELLE$100
How this compares
$8,690 in reported general payments places this provider in the 70th percentile of 130 urogynecology and reconstructive pelvic surgery providers in California.
See all urogynecology and reconstructive pelvic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 200 | $85,023 |
| MyrbetriqMirabegron | 44 | $23,462 |
| Trospium Chloride ErTrospium Chloride | 35 | $4,955 |
| Estradiol | 49 | $3,283 |
| Oxybutynin Chloride ErOxybutynin Chloride | 39 | $833 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $275 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Long Beach
- Kara de WinterLong Beach$7K
- Jocelyn CraigLong Beach$5K
- Andrew BrillSan Francisco$345K
- Bilal KaakiRiverside$301K
- Savitha KrishnanMountain View$243K
- Peter CastilloLos Gatos$95K
- Bruce Kahnla Jolla$79K
- Jennifer GruenenfelderOrange$76K
- Traci ItoSan Francisco$68K
- Tanaz FerzandiLos Angeles$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.